
Here are three options that help corporates link up with universities and research labs to tackle research and development hurdles.
SATT Aquitaine has signed up INRAE and its tech transfer arm for a five-year agreement to help commercialise its research.
The network of regional tech transfer offices in France added a combined 97 new spinouts to their portfolios last year, bringing the total to 672.
King’s College London has joined existing existing partners Imperial College London, University College London and University of Cambridge.
Orange Grove Bio has partnered SV Investment to jointly source therapeutics in South Korea and the US and create spinouts.
Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.
UTokyo Innovation Fund has signed up to a new incubator that will form companies commercialising university-industry collaborations.
University of Notre Dame's commercialisation hub will help Saint Mary's College accelerate its tech transfer and entrepreneurship output.
Chandigarh Angels Network has signed a memorandum of understanding to offer the Indian university's innovators early-stage funding and expertise.
University of Montreal, Laval University and ETS are to combine their tech transfer operations within a Quebec-wide initiative due to launch next spring.
University of Birmingham's cancer immunotherapy developer Revitope Oncology secured equity funding as part of a $160m alliance with Junshi Biosciences.
UCLA has been named as the first university partner of an academic collaboration bridge backed by Evotec, Samsara BioCapital and KCK.
Taiho Ventures has supplied a $10m extension for Caltech spinout Axial Biotherapeutics’ series B, bringing the total to $35m.
University of Calgary-born Parvus Therapeutics has inked an $800m deal with Genentech to develop and commercialise treatments for autoimmune diseases.
No posts to show.